The European Union’s antitrust commission blocked the re-acquisition of Grail by Illumina days after an FTC administrative law judge ruled in favor of the merger in the US.
The European Union’s antitrust regulators have blocked a planned merger between genetic sequencing company Illumina, Inc. and cancer detection test manufacturer Grail, Inc.
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.
As the EU Life Sciences Strategy aims to drive innovation, the medtech sector is pushing for a pivotal role in a mission intended to embrace green and digital transitions, address regulatory obstacles and reduce dependency on external sources.
The FDA's final LDT ruling was struck down in federal court last month. For now, diagnostic companies can commercialize under CLIA regulations or apply for FDA approval. McDermott and Tribun Health have shared insights on the risks, pros and cons of both regulatory routes.
Ireland’s NSAI reinstated under IVD Regulation designation list
